Does the media prefer BAH or CACI?

In the previous week, Booz Allen Hamilton had 6 more articles in the media than CACI International. MarketBeat recorded 9 mentions for Booz Allen Hamilton and 3 mentions for CACI International. Booz Allen Hamilton's average media sentiment score of 0.93 beat CACI International's score of 0.72 indicating that Booz Allen Hamilton is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Booz Allen Hamilton 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CACI International 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, BAH or LDOS?

Leidos has higher revenue and earnings than Booz Allen Hamilton. Leidos is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Booz Allen Hamilton $11.22B 0.84 $851M $6.89 11.42 Leidos $17.33B 0.90 $1.45B $10.92 11.41

Is BAH or LDOS more profitable?

Leidos has a net margin of 8.15% compared to Booz Allen Hamilton's net margin of 7.59%. Booz Allen Hamilton's return on equity of 76.07% beat Leidos' return on equity. Company Net Margins Return on Equity Return on Assets Booz Allen Hamilton 7.59% 76.07% 11.19% Leidos 8.15% 31.92% 11.23%

Does the media refer more to BAH or LDOS?

In the previous week, Leidos had 6 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 15 mentions for Leidos and 9 mentions for Booz Allen Hamilton. Leidos' average media sentiment score of 1.17 beat Booz Allen Hamilton's score of 0.93 indicating that Leidos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Booz Allen Hamilton 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Leidos 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Booz Allen Hamilton (BAH) Competitors

$78.69 -1.64 (-2.04%)

Closing price 03:58 PM Eastern

Extended Trading

$78.39 -0.30 (-0.39%)

As of 05:50 PM Eastern

Compare

BAH vs. CCRN, SAIC, CACI, LDOS, and CTSH

Should you buy Booz Allen Hamilton stock or one of its competitors? MarketBeat compares Booz Allen Hamilton with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Booz Allen Hamilton include Cross Country Healthcare (CCRN), Science Applications International (SAIC), CACI International (CACI), Leidos (LDOS), and Cognizant Technology Solutions (CTSH).

How does Booz Allen Hamilton compare to Cross Country Healthcare?

Booz Allen Hamilton (NYSE:BAH) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

91.8% of Booz Allen Hamilton shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 0.9% of Booz Allen Hamilton shares are owned by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Booz Allen Hamilton	$11.22B	0.84	$851M	$6.89	11.42
Cross Country Healthcare	$1.00B	0.42	-$94.85M	-$3.05	N/A

Booz Allen Hamilton currently has a consensus target price of $88.00, suggesting a potential upside of 11.83%. Cross Country Healthcare has a consensus target price of $12.72, suggesting a potential downside of 3.05%. Given Booz Allen Hamilton's higher probable upside, equities research analysts plainly believe Booz Allen Hamilton is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Booz Allen Hamilton	4 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Booz Allen Hamilton has a net margin of 7.59% compared to Cross Country Healthcare's net margin of -9.84%. Booz Allen Hamilton's return on equity of 76.07% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Booz Allen Hamilton	7.59%	76.07%	11.19%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Booz Allen Hamilton has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

In the previous week, Booz Allen Hamilton had 8 more articles in the media than Cross Country Healthcare. MarketBeat recorded 9 mentions for Booz Allen Hamilton and 1 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.94 beat Booz Allen Hamilton's score of 0.93 indicating that Cross Country Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Booz Allen Hamilton	Positive
Cross Country Healthcare	Positive

Summary

Booz Allen Hamilton beats Cross Country Healthcare on 11 of the 16 factors compared between the two stocks.

How does Booz Allen Hamilton compare to Science Applications International?

Booz Allen Hamilton (NYSE:BAH) and Science Applications International (NASDAQ:SAIC) are related mid-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.0%. Science Applications International pays an annual dividend of $1.48 per share and has a dividend yield of 1.3%. Booz Allen Hamilton pays out 34.3% of its earnings in the form of a dividend. Science Applications International pays out 19.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Booz Allen Hamilton has increased its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Booz Allen Hamilton has a net margin of 7.59% compared to Science Applications International's net margin of 5.55%. Booz Allen Hamilton's return on equity of 76.07% beat Science Applications International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Booz Allen Hamilton	7.59%	76.07%	11.19%
Science Applications International	5.55%	36.96%	10.32%

Booz Allen Hamilton presently has a consensus price target of $88.00, indicating a potential upside of 11.83%. Science Applications International has a consensus price target of $114.00, indicating a potential downside of 0.64%. Given Booz Allen Hamilton's higher possible upside, research analysts plainly believe Booz Allen Hamilton is more favorable than Science Applications International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Booz Allen Hamilton	4 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86
Science Applications International	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17

91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 76.0% of Science Applications International shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by insiders. Comparatively, 0.7% of Science Applications International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Science Applications International had 25 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 34 mentions for Science Applications International and 9 mentions for Booz Allen Hamilton. Booz Allen Hamilton's average media sentiment score of 0.93 beat Science Applications International's score of 0.72 indicating that Booz Allen Hamilton is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Booz Allen Hamilton	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Science Applications International	9 Very Positive mention(s)	6 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Booz Allen Hamilton has higher revenue and earnings than Science Applications International. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Science Applications International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Booz Allen Hamilton	$11.22B	0.84	$851M	$6.89	11.42
Science Applications International	$7.26B	0.69	$358M	$7.69	14.92

Booz Allen Hamilton has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market. Comparatively, Science Applications International has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

Summary

Booz Allen Hamilton beats Science Applications International on 13 of the 19 factors compared between the two stocks.

How does Booz Allen Hamilton compare to CACI International?

Booz Allen Hamilton (NYSE:BAH) and CACI International (NYSE:CACI) are both it consulting & other services companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

In the previous week, Booz Allen Hamilton had 6 more articles in the media than CACI International. MarketBeat recorded 9 mentions for Booz Allen Hamilton and 3 mentions for CACI International. Booz Allen Hamilton's average media sentiment score of 0.93 beat CACI International's score of 0.72 indicating that Booz Allen Hamilton is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Booz Allen Hamilton	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CACI International	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.8% of Booz Allen Hamilton shares are owned by institutional investors. Comparatively, 86.4% of CACI International shares are owned by institutional investors. 0.9% of Booz Allen Hamilton shares are owned by company insiders. Comparatively, 1.1% of CACI International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Booz Allen Hamilton has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market. Comparatively, CACI International has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

Booz Allen Hamilton currently has a consensus target price of $88.00, suggesting a potential upside of 11.83%. CACI International has a consensus target price of $627.82, suggesting a potential upside of 18.60%. Given CACI International's stronger consensus rating and higher probable upside, analysts plainly believe CACI International is more favorable than Booz Allen Hamilton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Booz Allen Hamilton	4 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86
CACI International	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

Booz Allen Hamilton has higher revenue and earnings than CACI International. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than CACI International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Booz Allen Hamilton	$11.22B	0.84	$851M	$6.89	11.42
CACI International	$8.63B	1.36	$499.83M	$24.24	21.84

Booz Allen Hamilton has a net margin of 7.59% compared to CACI International's net margin of 5.86%. Booz Allen Hamilton's return on equity of 76.07% beat CACI International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Booz Allen Hamilton	7.59%	76.07%	11.19%
CACI International	5.86%	15.90%	6.86%

Summary

CACI International beats Booz Allen Hamilton on 9 of the 17 factors compared between the two stocks.

How does Booz Allen Hamilton compare to Leidos?

Booz Allen Hamilton (NYSE:BAH) and Leidos (NYSE:LDOS) are both it consulting & other services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 76.1% of Leidos shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by company insiders. Comparatively, 0.8% of Leidos shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Booz Allen Hamilton currently has a consensus price target of $88.00, suggesting a potential upside of 11.83%. Leidos has a consensus price target of $187.50, suggesting a potential upside of 50.51%. Given Leidos' stronger consensus rating and higher probable upside, analysts clearly believe Leidos is more favorable than Booz Allen Hamilton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Booz Allen Hamilton	4 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86
Leidos	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.57

Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.0%. Leidos pays an annual dividend of $1.72 per share and has a dividend yield of 1.4%. Booz Allen Hamilton pays out 34.3% of its earnings in the form of a dividend. Leidos pays out 15.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Booz Allen Hamilton has raised its dividend for 14 consecutive years and Leidos has raised its dividend for 6 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Leidos has higher revenue and earnings than Booz Allen Hamilton. Leidos is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Booz Allen Hamilton	$11.22B	0.84	$851M	$6.89	11.42
Leidos	$17.33B	0.90	$1.45B	$10.92	11.41

In the previous week, Leidos had 6 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 15 mentions for Leidos and 9 mentions for Booz Allen Hamilton. Leidos' average media sentiment score of 1.17 beat Booz Allen Hamilton's score of 0.93 indicating that Leidos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Booz Allen Hamilton	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Leidos	12 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Leidos has a net margin of 8.15% compared to Booz Allen Hamilton's net margin of 7.59%. Booz Allen Hamilton's return on equity of 76.07% beat Leidos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Booz Allen Hamilton	7.59%	76.07%	11.19%
Leidos	8.15%	31.92%	11.23%

Booz Allen Hamilton has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, Leidos has a beta of 0.5, indicating that its stock price is 50% less volatile than the broader market.

Summary

Leidos beats Booz Allen Hamilton on 14 of the 20 factors compared between the two stocks.

How does Booz Allen Hamilton compare to Cognizant Technology Solutions?

Cognizant Technology Solutions (NASDAQ:CTSH) and Booz Allen Hamilton (NYSE:BAH) are both it consulting & other services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Cognizant Technology Solutions has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.32, suggesting that its share price is 68% less volatile than the broader market.

Cognizant Technology Solutions presently has a consensus target price of $72.68, indicating a potential upside of 35.84%. Booz Allen Hamilton has a consensus target price of $88.00, indicating a potential upside of 11.83%. Given Cognizant Technology Solutions' stronger consensus rating and higher probable upside, equities analysts plainly believe Cognizant Technology Solutions is more favorable than Booz Allen Hamilton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cognizant Technology Solutions	0 Sell rating(s)	13 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.43
Booz Allen Hamilton	4 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86

92.4% of Cognizant Technology Solutions shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 0.4% of Cognizant Technology Solutions shares are held by company insiders. Comparatively, 0.9% of Booz Allen Hamilton shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Cognizant Technology Solutions had 22 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 31 mentions for Cognizant Technology Solutions and 9 mentions for Booz Allen Hamilton. Cognizant Technology Solutions' average media sentiment score of 0.95 beat Booz Allen Hamilton's score of 0.93 indicating that Cognizant Technology Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cognizant Technology Solutions	14 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Booz Allen Hamilton	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cognizant Technology Solutions has a net margin of 10.41% compared to Booz Allen Hamilton's net margin of 7.59%. Booz Allen Hamilton's return on equity of 76.07% beat Cognizant Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cognizant Technology Solutions	10.41%	17.50%	12.94%
Booz Allen Hamilton	7.59%	76.07%	11.19%

Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.5%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.0%. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 34.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognizant Technology Solutions has raised its dividend for 6 consecutive years and Booz Allen Hamilton has raised its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cognizant Technology Solutions has higher revenue and earnings than Booz Allen Hamilton. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Cognizant Technology Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cognizant Technology Solutions	$21.11B	1.20	$2.23B	$4.60	11.63
Booz Allen Hamilton	$11.22B	0.84	$851M	$6.89	11.42

Summary

Cognizant Technology Solutions beats Booz Allen Hamilton on 14 of the 19 factors compared between the two stocks.

Get Booz Allen Hamilton News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BAH vs. The Competition

Export

Metric	Booz Allen Hamilton	Consulting Industry	Business Sector	NYSE Exchange
Market Cap	$9.42B	$4.23B	$6.57B	$23.08B
Dividend Yield	2.81%	2.38%	2.96%	4.09%
P/E Ratio	11.42	14.65	29.39	31.02
Price / Sales	0.84	2.00	414.58	14.81
Price / Cash	10.56	18.34	24.63	24.78
Price / Book	8.59	5.89	5.90	4.67
Net Income	$851M	$245.85M	$203.93M	$1.07B
7 Day Performance	-2.87%	-1.56%	1.02%	-0.67%
1 Month Performance	0.45%	-6.23%	1.37%	0.22%
1 Year Performance	-25.06%	-27.55%	40.53%	25.44%

Booz Allen Hamilton Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BAH Booz Allen Hamilton	4.178 of 5 stars	$78.69 -2.0%	$88.00 +11.8%	-22.2%	$9.42B	$11.22B	11.42	31,500
CCRN Cross Country Healthcare	2.5412 of 5 stars	$13.05 flat	$12.72 -2.5%	-0.5%	$421.95M	$1.05B	N/A	6,784
SAIC Science Applications International	2.99 of 5 stars	$100.01 flat	$110.78 +10.8%	N/A	$4.34B	$7.26B	13.01	23,000	Trending News Earnings Report Dividend Announcement Analyst Forecast
CACI CACI International	3.7513 of 5 stars	$502.03 +0.1%	$635.60 +26.6%	+26.4%	$11.08B	$8.63B	20.71	25,000	Gap Down
LDOS Leidos	4.8086 of 5 stars	$126.11 +0.1%	$193.64 +53.6%	-10.4%	$15.85B	$17.17B	11.55	47,000	Positive News Analyst Downgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BAH) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Booz Allen Hamilton (BAH) Competitors

BAH vs. CCRN, SAIC, CACI, LDOS, and CTSH

How does Booz Allen Hamilton compare to Cross Country Healthcare?

Summary

How does Booz Allen Hamilton compare to Science Applications International?

Summary

How does Booz Allen Hamilton compare to CACI International?

Summary

How does Booz Allen Hamilton compare to Leidos?

Summary

How does Booz Allen Hamilton compare to Cognizant Technology Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAH vs. The Competition

Booz Allen Hamilton Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Booz Allen Hamilton (BAH) Competitors

BAH vs. CCRN, SAIC, CACI, LDOS, and CTSH

How does Booz Allen Hamilton compare to Cross Country Healthcare?

Do insiders & institutionals hold more shares of BAH or CCRN?

Which has stronger earnings & valuation, BAH or CCRN?

Do analysts recommend BAH or CCRN?

Is BAH or CCRN more profitable?

Which has more volatility & risk, BAH or CCRN?

Does the media prefer BAH or CCRN?

Summary

How does Booz Allen Hamilton compare to Science Applications International?

Is BAH or SAIC a better dividend stock?

Is BAH or SAIC more profitable?

Do analysts rate BAH or SAIC?

Do insiders & institutionals believe in BAH or SAIC?

Does the media refer more to BAH or SAIC?

Which has better earnings and valuation, BAH or SAIC?

Which has more risk & volatility, BAH or SAIC?

Summary

How does Booz Allen Hamilton compare to CACI International?

Does the media prefer BAH or CACI?

Do insiders & institutionals hold more shares of BAH or CACI?

Which has more volatility & risk, BAH or CACI?

Do analysts recommend BAH or CACI?

Which has better valuation & earnings, BAH or CACI?

Is BAH or CACI more profitable?

Summary

How does Booz Allen Hamilton compare to Leidos?

Do institutionals and insiders believe in BAH or LDOS?

Do analysts rate BAH or LDOS?

Is BAH or LDOS a better dividend stock?

Which has stronger earnings & valuation, BAH or LDOS?

Does the media refer more to BAH or LDOS?

Is BAH or LDOS more profitable?

Which has more risk & volatility, BAH or LDOS?

Summary

How does Booz Allen Hamilton compare to Cognizant Technology Solutions?

Which has more volatility & risk, CTSH or BAH?

Do analysts rate CTSH or BAH?

Do insiders & institutionals have more ownership in CTSH or BAH?

Does the media refer more to CTSH or BAH?

Is CTSH or BAH more profitable?

Is CTSH or BAH a better dividend stock?

Which has better earnings & valuation, CTSH or BAH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAH vs. The Competition

Booz Allen Hamilton Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools